AHA Calls for Guidelines: Sleep Disorders Linked to Increased Cardiovascular Risk
The American Heart Association panel found that sleep disorders are associated with adverse cardiometabolic risk profiles and outcomes.
The American Heart Association panel found that sleep disorders are associated with adverse cardiometabolic risk profiles and outcomes.
Although patients in the CPAP group experienced improvements in quality of life, the therapy had no significant effects on the composite end point of death from any cardiovascular cause, MI, stroke, or hospitalization for various cardiovascular events.